C3 Reduct ODN

C3 Reduct ODN
Studies & Documents (17)
News (7)

Curcuma longa
95% tetrahydrocurcuminoids
Sectors
Feed - Pet Food
Nutrition
Topical
Properties
Acne, Antimicrobial, Preservative
Anti inflammatory, Pain, Joints, Bones
Antioxidant
Blood Sugar Support
Cholesterol Management
Digestive, Biotic, Appetite
Liver, Kidney, Detox
Nutracosmetic
Oral care
Skin Lightening, Whitening
Weight Management, Slimming

C3 Reduct ODN

C3® Reduct: 'the power of curcumin reductive metabolites' - Tetrahydrocurcuminoid: the directly active form of turmeric

C3® Reduct allows to use the active form of turmeric curcuminoids, and move away from the myth of bioavailability. Colorless and highly stable, suitable for gummies, gels, bars, tablets, premixes etc…
Curcuminoids exert their effects through gastrointestinal as well as systemic routes. They are metabolized to Tetrahydrocurcuminoids (THCs), depending also on their bio-availability. Many ‘improved’ curcuma extracts include new technologies, new process or formulations with chemical, said to “improve the bio availability”, in the serum and sometimes to the detriment of the real bio-active forms. Besides, there’s the challenge to be considered as novel foods since they have been developed after may 1997.
C3® Reduct overcomes the bioavailability limitation of the parent curcuminoids in the most functional way since directly providing the active metabolite. Research has shown that C3® Reduct is a remarkable antioxidant, superior even to curcumin itself in this respect. The beneficial impact of THCs on colonic health also has received strong scientific reports. THCs are also an excellent anti-inflammatory agent.
C3® Reduct, which so contains directly the curcuminoid metabolites - THCs - has obtained Novel Food approval from the EFSA (end 12/2021), daily dose up to 140mg. This may well be the first time a metabolite of a nutrient has been approved as a Novel Food.
It’s a Creamy-white crystalline powder (cf. easier cleaning of equipment), with a total content of 95% THCs, the hydrogenated derivatives of yellow curcuminoids (mainly curcumin, demethoxycurcumin, and bisdemethoxycurcumin) from the rhizomes of turmeric.
Regular studies are performed with tetrahydrocyurcuminoids (last on november 2020: Efficacy for the Treatment of Canker Sore and Gingivitis).
In cosmetic, it brings a strong skin whitening, is found to have anti-inflammatory, antioxidant and tyrosinase inhibitory effects. Also against mycosis on skin, hair and nails (antifungal) - see our TetraPure.

Curcuma - Free curcumins, 3 peaks, anti-inflammatory, antioxidant, digestion ...

Curcuma longa is a plant of the ginger family that has been used for centuries in Asia, also known as Indian saffron, it is among the oldest natural medications in the world. Indeed, the rhizome of this perennial plant has been used for thousands of years in traditional Chinese and Ayurvedic medicine.
In China, its rhizomes were dried and powdered to be used to soothe pain and treat congestion. In Ayurvedic medicine, curcuma was immediately appreciated for its anti-inflammatory and antioxidant properties. It can even be seen in the Atharva-Veda - a sacred text of Hinduism - around the 4th century. It is referred to there as "Hrudroga", meaning a remedy useful in the treatment of heart problems.
Many properties are recognized for curcuma: anti-inflammatory, helps digestion, IBD, regulator of blood sugar (type 2 diabetes), hepatoprotector, anti-cancer ...
The curcuma rhizome contains a set of substances, curcuminoids, of which curcumin is the most abundant. Chemically, these substances have marked antioxidant properties, as well as anti-inflammatory properties. In addition, curcumin has shown, in cell cultures, an ability to block the multiplication of several types of cancer cells. Curcuminoids are metabolized in the body, especially to tetrahydrocurcuminoids.

Are you interested in our solutions and want to know more?

Becarre Natural represents, distributes and develops natural actives extracts from plants for nutrition health and cosmeceutical.

Contact us